Method of using adenoviral vectors to induce an immune response

Details for Australian Patent Application No. 2005243730 (hide)

Owner GenVec, Inc. The Government of the United States of America, as represented by the Secretary, Department of Health and Human Services

Inventors Kong, Wing-Pui; Cheng, Cheng; Gall, Jason G. D.; Nabel, Gary J.; King, C. Richter

Agent Fisher Adams Kelly

Pub. Number AU-B-2005243730

PCT Pub. Number WO2005/110492

Priority 60/561,341 12.04.04 US

Filing date 12 April 2005

Wipo publication date 24 November 2005

Acceptance publication date 27 May 2010

International Classifications

A61K 39/21 (2006.01) Medicinal preparations containing antigens or antibodies - Retroviridae, e.g. equine infectious anemia virus

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

C07K 14/16 (2006.01) Peptides having more than 20 amino acids

C12N 15/861 (2006.01) Mutation or genetic engineering - Adenoviral vectors

Event Publications

2 November 2006 PCT application entered the National Phase

  PCT publication WO2005/110492 Priority application(s): WO2005/110492

27 May 2010 Application Accepted

  Published as AU-B-2005243730

23 September 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005243732-Aryl sulfones and uses related thereto

2005243727-Multi-site injection system